Aurora Cannabis (ACB) Change in Receivables (2017 - 2018)
Aurora Cannabis (ACB) posted quarterly Change in Receivables of -$7.9 million for Q4 2018, down 5571.69% year-over-year from $145232.6 in Q4 2017, and down 576.96% quarter-over-quarter from $1.7 million in Q3 2018.
Aurora Cannabis (ACB) Change in Receivables (2017 - 2018) Analysis & Trends
Aurora Cannabis (ACB) has reported Change in Receivables for 2 consecutive years, with -$7.9 million the latest figure, recorded in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Aurora Cannabis | 243.01 Mn | 170.70 Mn | 25.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | -7.95 Mn |
| Dec 31, 2018 | -7.95 Mn |
| Sep 30, 2018 | 1.67 Mn |
| Sep 30, 2018 | 1.67 Mn |
| Dec 31, 2017 | -140,111.32 |
| Dec 31, 2017 | -140,111.32 |
| Sep 30, 2017 | 178,619.02 |
| Sep 30, 2017 | 178,619.02 |